June 25, 2018 Price forecast | 2 weeks: 4.79% | 1 month: 7.28% | 3 months: 8.26%


XERS stock forecast

Our latest prediction for Xeris Pharmaceuticals, Inc.'s stock price was made on the June 25, 2018 when the stock price was at 19.10$.

In the short term (2weeks), XERS's stock price should outperform the market by 4.79%. During that period the price should oscillate between -2.34% and +8.12%.

In the medium term (3months), XERS's stock price should outperform the market by 8.26%. During that period the price should oscillate between -5.37% and +21.39%.


About Xeris Pharmaceuticals, Inc.

Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol™ and XeriJect™ formulation technologies. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Austin, TX.

At the moment the company generates 2M USD in revenues.

On its last earning announcement, the company reported a loss of -4.21$ per share.

The book value per share is 5.25$

Xeris Pharmaceuticals, Inc. website


Three months stock forecastJune 25, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
2M 98.00% -110M - -113M -4.21 - - 25M 5.25 -93M -1M -94M